These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3302350)

  • 1. [Recovery of immune function after bone marrow transplantation].
    Takagi S; Miura Y
    Rinsho Ketsueki; 1987 Mar; 28(3):323-30. PubMed ID: 3302350
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F; Raffoux C; Griscelli C; Fischer A
    J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodeficiency following human marrow transplantation: in vitro studies.
    Neely JE; Neely AN; Kersey JH
    Transplant Proc; 1978 Mar; 10(1):229-31. PubMed ID: 345562
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunodeficiency following allogeneic bone marrow transplantation.
    Gale RP; Opelz G; Mickey MR; Graze PR; Saxon A
    Transplant Proc; 1978 Mar; 10(1):223-7. PubMed ID: 147534
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro correlates of graft-host tolerance after HLA-matched and mismatched marrow transplants: suggestions from limiting dilution analysis.
    Rosenkrantz K; Keever C; Kirsch J; Horvath A; Bhimani K; O'Reilly R; Dupont B; Flomenberg N
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):98-103. PubMed ID: 3321650
    [No Abstract]   [Full Text] [Related]  

  • 6. What is graft versus host disease?
    van Bekkum DW
    Bone Marrow Transplant; 1991; 7 Suppl 2():110-1. PubMed ID: 1878668
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression, graft-versus-host disease, and infection after bone marrow transplantation.
    Kramer BS; Elfenbein GJ
    J Fla Med Assoc; 1984 May; 71(5):321-8. PubMed ID: 6429272
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow transplantation for severe combined immune deficiency in an infant with chimerism due to intrauterine-derived maternal lymphocytes: donor engraftment documented by chromosomal marker studies.
    Borzy MS; Magenis E; Tomar D
    Am J Med Genet; 1984 Jul; 18(3):527-39. PubMed ID: 6383041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic marrow grafts in man using cyclophosphamide.
    Santos GW; Sensenbrenner LL; Burke PJ; Mullins GM; Anderson PN; Tutschka PJ; Braine HG; Davis TE; Humphrey RL; Abeloff MD; Bias WB; Borgaonkar DS; Slavin RE
    Transplant Proc; 1974 Dec; 6(4):345-8. PubMed ID: 4155151
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation.
    Rao SK; Pandya BG; Bichile SK; Mehta PJ
    J Assoc Physicians India; 1984 Oct; 32(10):903-7. PubMed ID: 6394585
    [No Abstract]   [Full Text] [Related]  

  • 12. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?
    Storek J; Ferrara S; Ku N; Giorgi JV; Champlin RE; Saxon A
    Bone Marrow Transplant; 1993 Oct; 12(4):387-98. PubMed ID: 8275039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors.
    Löwenberg B; Wagemaker G; van Bekkum DW; Sizoo W; Sintnicolaas K; Hendriks WD; Hagenbeek A
    Bone Marrow Transplant; 1986 Dec; 1(2):133-40. PubMed ID: 3332128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell depletion of human bone marrow for allogeneic marrow transplantation.
    Farrelly H; Cooley M; O'Flaherty E; Biggs J; Atkinson K
    Transplant Proc; 1987 Apr; 19(2):2855-7. PubMed ID: 3551227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fractionated bone marrow transplantation in a case of severe combined immunodeficiency].
    García Rodríguez MC; Gómez-de la Concha E; Fontán G; Alba J; Guerrero J; Peña P; Ojeda JA
    An Esp Pediatr; 1982 Jul; 17(1):71-7. PubMed ID: 6753678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic reconstititution of a patient with combined immunodeficiency disease.
    Biggar WD; Good RA; Park BH
    J Pediatr; 1972 Aug; 81(2):301-6. PubMed ID: 4402890
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in man.
    Butturini A; Bortin MM; Seeger RC; Gale RP
    Prog Clin Biol Res; 1987; 244():371-90. PubMed ID: 3310000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation in children.
    Dooren LJ; Kamphuis RP; de Koning J; Vossen JM
    Semin Hematol; 1974 Jul; 11(3):369-82. PubMed ID: 4599790
    [No Abstract]   [Full Text] [Related]  

  • 19. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Yamada S; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1999 Nov; 24(9):1005-7. PubMed ID: 10556960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.